MedTrace Logo

A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma

NCT04616573 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2022-12-01

Study results available
· View outcomes & findings →

Summary

To prospectively compare the clinical effect of the OMNI surgical system in eyes with Open Angle Glaucoma.

Conditions

  • Glaucoma, Open-Angle

Interventions

DEVICE

OMNI® Surgical System

Ab-interno transluminal viscoelastic delivery and trabeculotomy performed with the OMNI Surgical System

DEVICE

iStent inject

Trabecular meshwork implantation

Sponsors & Collaborators

  • Sight Sciences, Inc.

    lead INDUSTRY

Principal Investigators

  • Kavita Dhamdhere, MD, PhD · Sight Sciences, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-13
Primary Completion
2021-01-20
Completion
2021-01-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04616573 on ClinicalTrials.gov